Imunon, Inc. (IMNN) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+252.7%

$3.07

vs $0.87 price

Levered DCF

$3.66

After debt service

Piotroski score

1 / 9

Weak

Altman Z-score

-42.64

Distress zone

Rating

C+

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-0.56×	-0.68×	-0.36×	-0.31×	-0.16×	-1.21×	-2.55×	-2.4×
P/B	1.15×	2.96×	0.53×	0.38×	0.06×	1.4×	2.95×	1.37×
P/S	0×	0×	0×	22.18×	6.74×	52.19×	85.87×	57.02×
EV / EBITDA	-0.02×	-0.44×	-0.14×	-0.18×	0.46×	-0.71×	-2.86×	-1.16×
Gross margin	0.0%	0.0%	0.0%	100.0%	100.0%	100.0%	100.0%	100.0%
Operating margin	0.0%	0.0%	0.0%	-4984.3%	-4201.4%	-3697.3%	-4113.1%	-4213.0%
Net margin	0.0%	0.0%	0.0%	-7179.6%	-4153.9%	-4296.7%	-3370.3%	-2376.7%
Current ratio	2.32×	1.67×	2.47×	3.66×	7.67×	2.79×	2.06×	4.61×
Debt / equity	0.14×	0.27×	0.12×	0.21×	0.12×	0.33×	0.78×	0.45×
Interest coverage	0×	0×	-106.71×	-4.96×	-36.86×	-14.3×	-14.76×	-29.58×
Dividend yield	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	-0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-205.3%	-438.7%	-145.8%	-122.4%	-37.2%	-115.4%	-115.7%	-57.0%
Return on invested capital	-181.5%	-355.4%	-131.5%	-67.1%	-29.0%	-52.7%	-56.9%	-27.5%
Return on assets	-118.0%	-191.6%	-89.0%	-81.6%	-28.0%	-57.2%	-44.0%	-25.4%
Free cash flow yield	-175.3%	-150.2%	-275.3%	-210.7%	-490.7%	-59.9%	-48.0%	-25.2%
Earnings yield	-179.2%	-148.1%	-275.9%	-323.7%	-616.3%	-82.3%	-39.2%	-41.7%
Enterprise value	$315.6K	$7.8M	$2.9M	$5.9M	-$9.6M	$15.1M	$47.4M	$24.6M
Net debt / EBITDA	0.56×	0.26×	0.21×	0.16×	0.62×	0.52×	-0.27×	0.19×
Cash conversion cycle (days)	0	0	0	94	79	0	16	50